London, September 22
The UK government added Covishield, the India-made Oxford / AstraZeneca COVID-19 vaccine, to an updated international travel advisory on Wednesday.
The move follows widespread condemnation of vaccines manufactured by the Serum Institute of India that are not included in a list of eligible COVID-19 vaccines recognized by Britain’s revised international travel standards, as of October 4 .
The updated notice means Indians fully vaccinated with Covishield will no longer be required to undergo mandatory 10-day self-isolation at home or at a declared location upon entering England.
“The formulations of the 4 vaccines listed, such as AstraZeneca Covishield, AstraZeneca Vaxzevria and Moderna Takeda, are considered to be approved vaccines”, reads the opinion of the UK Department for Transport (DfT) and the Department for Health and Human Rights. Social Affairs (DHSC).
“You must have taken a full course of an approved vaccine at least 14 days before you arrive in England,” he adds.
This decision will also mean that a pre-departure PCR test is no longer required as long as vaccinated travelers pre-book a day two test after arriving in England and complete the mandatory passenger tracing form in advance. .
From October 4, the current red, orange and green country traffic light system based on COVID-19 risk levels will be removed and replaced with a single red list. However, until this latest update, Indians vaccinated with vaccines in India – including Covishield – were not recognized as vaccinated under UK eligibility criteria. PTI